phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 and Adenocarcinoma

phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 has been researched along with Adenocarcinoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Redding, TW; Schally, AV	1
Paz-Bouza, JI; Redding, TW; Schally, AV; Zalatnai, A	1

Other Studies

2 other study(ies) available for phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 and Adenocarcinoma

Article	Year
Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 1987, Volume: 84, Issue:20 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Capsules; Drug Compounding; Drug Synergism; Gonadotropin-Releasing Hormone; Male; Octreotide; Organ Size; Prostate; Prostatic Neoplasms; Rats; Somatostatin; Triptorelin Pamoate	1987
Histologic changes in the rat prostate cancer model after treatment with somatostatin analogs and D-Trp-6-LH-RH. The Prostate, 1988, Volume: 12, Issue:1 Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Epithelium; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Male; Octreotide; Organ Size; Prolactin; Prostate; Prostatic Neoplasms; Rats; Somatostatin; Testis; Testosterone; Triptorelin Pamoate	1988

Article

Year

Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.

Proceedings of the National Academy of Sciences of the United States of America, 1987, Volume: 84, Issue:20

Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Capsules; Drug Compounding; Drug Synergism; Gonadotropin-Releasing Hormone; Male; Octreotide; Organ Size; Prostate; Prostatic Neoplasms; Rats; Somatostatin; Triptorelin Pamoate

1987

Histologic changes in the rat prostate cancer model after treatment with somatostatin analogs and D-Trp-6-LH-RH.

The Prostate, 1988, Volume: 12, Issue:1

Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Epithelium; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Male; Octreotide; Organ Size; Prolactin; Prostate; Prostatic Neoplasms; Rats; Somatostatin; Testis; Testosterone; Triptorelin Pamoate

1988